EPHA2 and cancer: Another newly identified stress-induced antigen that is recognized by Vδ1 TCR is ephrin type-A receptor 2 (EphA2) (Figure 1B), which is upregulated upon AMP-activated protein kinase (AMPK)-dependent metabolic reprogramming of cancer cells.